REL/STEAP4

Ruikang Guo1, Bingchuan Geng1, Wai Yen Yim1

  • 1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei, 430022, China.

PubMed
概括

铁过载和铁亡驱动了动脉膜疾病 (CAVD) 的进展. 抑制铁和向REL/STEAP4通路为CAVD提供了一个有前途的新疗法.